Based on microarray analysis, we focused our investigation on the Th2-associated chemokine receptor CCR3

Based on microarray analysis, we focused our investigation on the Th2-associated chemokine receptor CCR3. Compared with WT (wild-type), a significant decrease in FMN survival 4 weeks after axotomy was observed in CCR3/mice. Additionally, compared with WT, a significant decrease in FMN survival 4 weeks after axotomy was observed inRag2/(recombination activating gene-2-deficient) mice adoptively transferred CD4+T-cells isolated from CCR3/mice, but not in CCR3/mice adoptively transferred CD4+T-cells derived from WT mice. These results provide a basis for further investigation into the co-operation between CD4+T-cell- and CCR3-mediated neuroprotection after FMN injury. Keywords:CCR3, chemokine receptor, facial nerve axotomy, neuroprotection Abbreviations:ALS, amyotrophic lateral sclerosis; CNS, central nervous system; DEPC, diethyl pyrocarbonate; DPA, days post-axotomy; FMN, facial motoneuron(s); GFAP, glial fibrillary acidic protein; GPCR, G-protein-coupled receptor; PACAP, pituitary adenylate cyclase-activating polypeptide; PNS, peripheral nervous system; Rag2, recombination activating gene-2; WT, wild-type == INTRODUCTION == Our laboratory has previously demonstrated a positive role for CD4+T-cells in FMN (facial motoneuron) survival after peripheral facial nerve axotomy at the stylomastoid foramen in the mouse (Serpe et al., 1999,2003).Raivich et al. (1998)have found a maximum increase in T-cell infiltration of the axotomized mouse facial motor nucleus between 7 and 21 days after injury. Furthermore,Ha et al. (2007)demonstrated a significant increase of CD4+T-cells AFP464 in the facial motor nucleus after facial nerve injury. In support of the findings byRaivich et al. (1998)andHa et al. (2007), our laboratory has shown that CNS (central nervous system)-resident microglia are necessary to reactivate CD4+T-cells centrally (Byram et al., 2004), suggesting the mechanism of peripheral CD4+T-cell recruitment to the injured facial motor nucleus from the draining cervical lymph nodes. Once activated, nave CD4+T-cells differentiate into IL-4 (interleukin-4)-positive (IL-4+) Th2 or IFN (interferon )-positive (IFN-+) Th1 effector cells (Stout and Bottomly, 1989). Previous work in AFP464 our laboratory has found that both Th2 and Th1 subsets develop in draining lymph nodes after facial nerve axotomy (Xin et al., 2008), but that the Th2 effector subset alone is necessary for immune-mediated neuroprotection (Deboy et al., 2006). Additionally,Armstrong et al. (2003)demonstrated increased mRNA levels for PACAP (pituitary adenylate cyclase-activating polypeptide) in FMN after facial nerve axotomy. Since cultured murine microglia exposed to PACAP increase Th2-associated chemokine expression (Wainwright et al., 2008), the results suggest that, following a peripheral nerve injury outside the BBB (bloodbrain barrier), microglia, which are capable of antigen presentation centrally (Carson et al., 1999), recruit Th2 cells to the facial motor nucleus. However, to respond to Th2-associated chemokines, Th2 effector cells must express the cognate Th2-associated chemokine receptors. The recruitment of lymphocytes to Gja5 different bodily compartments is a highly regulated process that involves chemokine receptors (Rand et al., 1996). Chemokine receptors are GPCRs (G-protein-coupled receptors) that, upon activation, induce chemotaxis and calcium mobilization. Different subsets of lymphocytes express different chemokine receptors, reflecting their unique migration patterns. For example, nave CD4+T-cells that develop into the Th2 subset express the Th2-associated chemokine receptor CCR3 (Sallusto et al., 1997). Furthermore, while several Th2-associated chemokine receptors have been demonstrated to be up-regulated by Th2 effector cells (Sallusto et al., 1998;Zingoni et al., 1998), experiments with receptor antagonists have demonstrated a critical requirement of CCR3 for Th2 cell accumulation after antigenic challenge (Mori et al., 2007). In summary, CD4+T-cells are present in the facial motor nucleus after facial nerve injury (Ha et al., 2007), interact with microglia (Byram et al., 2004) and protect FMN through a Th2 AFP464 cell-dependent mechanism (Deboy et al., 2006). Since Th2 cells are recruited by means of Th2-associated chemokine receptors, we hypothesized that Th2-associated chemokine receptors increase in the facial motor nucleus after peripheral facial nerve injury. To investigate this hypothesis, we initially used microarray analysis to analyse AFP464 Th2-associated chemokine receptor mRNA levels in the facial motor nucleus at 7 DPA (days post-axotomy), a time point consistent with significant AFP464 T-cell infiltration (Raivich et al., 1998). Based on microarray analysis, we focused our investigation on the Th2-associated chemokine receptor CCR3. In addition, co-immunofluorescence revealed that CCR3 localizes to FMN and is.